Quantification of the effects of mutations on receptor tyrosine kinase (RTK) activation in mammalian cells

Lijuan He1, Kalina Hristova

  • 1Department of Materials Science and Engineering, Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD, 21218, USA.

Insights

Single amino acid mutations in receptor tyrosine kinases (RTKs) can cause disease by increasing receptor activity. This study details a Western blot method to precisely quantify how mutations affect RTK activation in mammalian cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Single amino acid mutations in receptor tyrosine kinases (RTKs) are implicated in various human diseases.
  • Dysregulation of RTK signaling, often due to mutations, leads to uncontrolled cellular proliferation and pathogenesis.

Purpose of the Study:

  • To present a detailed protocol for quantifying the impact of specific mutations on RTK activation.
  • To establish a reliable method for comparing wild-type and mutant RTK phosphorylation levels.

Main Methods:

  • Utilizes Western blotting to measure receptor phosphorylation.
  • Employs techniques to ensure identical expression levels of wild-type and mutant RTKs in mammalian cells.
  • Involves direct comparison of phosphorylation signals between wild-type and mutant receptors.

Main Results:

  • Provides a quantifiable measure of mutation-induced changes in RTK activation.
  • Demonstrates a method for assessing the functional consequences of RTK mutations at the molecular level.
  • Establishes a standardized approach for RTK activation studies.

Conclusions:

  • The presented protocol enables accurate assessment of how single amino acid substitutions affect RTK activity.
  • This method facilitates the study of disease mechanisms driven by RTK mutations.
  • Offers a valuable tool for research in cancer biology and drug development targeting RTKs.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.2K